Embodiments of the present disclosure are generally related to polyurethane-based insulation boards, and are more specifically related to polyurethane-based insulation boards including an open cell polyurethane/polyisocyanurate foam layer and a closed cell polyurethane/polyisocyanurate foam layer.
Insulation systems for external walls, such as concrete or masonry walls, have been proposed. The combination of the thermal insulation product applied on the outer face of the external wall and faced by a rendering system is referred to as an external thermal insulation composite system (ETICS). External thermal insulation composite systems are often the preferred choice in construction over other solutions, both for new dwellings and for refurbishment of existing building stock.
Most common external thermal insulation composite systems employ expanded polystyrene (EPS) as in insulating material. Polyurethane may typically provide certain favorable properties over lower cost alternatives, such as thermal insulation, strength, and limited water uptake. Additionally, closed cell polyurethane foam may provide improved insulation over EPS. However, such closed cell polyurethane foams may exhibit diminished dimensional stability as compared to EPS. Accordingly, it is proposed to combine open cell and closed cell polyurethane based insulation boards with external walls in external thermal insulation composite systems.
According to one or more embodiments herein, an external thermal insulation composite system includes a concrete or masonry wall and a multilayer thermal insulation board disposed on the concrete or masonry wall. The multilayer thermal insulation board includes at least one closed cell foam layer comprising polyurethane and polyisocyanurate having an open cell volume of less than 20% by volume according to ASTM D 6226 and at least one open cell foam layer comprising polyurethane and polyisocyanurate having an open cell volume of greater than 80% by volume according to ASTM D 6226. The closed cell layer may provide insulation properties while the open cell layer of the multilayer thermal insulation board may help mitigate the effect of dimensional changes of the closed cell layer.
Referring to
The system may further include an adhesive 104 disposed directly on an outer surface of the external wall 102. The adhesive 104 may be placed between the outer surface of the external wall 102 and an insulation component 106. In various embodiments, the adhesive 104 may be a flexible adhesive, such as a foam adhesive, silicone adhesive, hot melt adhesive, or cold melt adhesives. In some particular embodiments, the adhesive may be a polyurethane foam adhesive, such as the polyurethane foam adhesive commercially available as Insta-Stik™ from The Dow Chemical Company (Midland, Mich.). Although various embodiments described herein describe an adhesive 102 for attaching the insulation component 106 to the external wall 102, it is contemplated that the insulation component 106 may be attached to the external wall 102 in other ways, such as through the use of a mechanical fixing device.
According to various embodiments, the insulation component 106 may be a multilayer thermal insulation board that includes a closed cell polyurethane/polyisocyanurate foam layer 202 having an open cell volume of less than 20% by volume according to ASTM D 6226 and an open cell polyurethane/polyisocyanurate foam layer 204 having an open cell volume of greater than 80% by volume according to ASTM D 6226 (shown in
Still referring to
The external thermal insulation composite system 100 depicted in
Finally, a top coat 112 is positioned on the external thermal insulation composite system 100. The top coat may include, by way of example and not limitation, grained and scratched renders, decorative panels, brick effects, or actual brick slips. Other types of top coats are contemplated, depending on the particular embodiment.
Having generally described the external thermal insulation composite system 100, the insulation component 106 will now be described in greater detail, with reference to
Closed Cell Polyurethane/Polyisocyanurate Foam Layer
In various embodiments, the closed cell polyurethane/polyisocyanurate foam layer may be formed from a polymer matrix formed by reacting an isocyanate-reactive component with an isocyanate component. In particular, the polymer matrix may include urethane groups, isocyanurate groups, and/or urea groups.
The isocyanate-reactive component includes one or more polyols. In some embodiments, the isocyanate-reactive mixture includes at least one polyester polyol. Various molecular weights are contemplated for the polyester polyol. The polyester polyol may contain multiple ester groups per molecule and have an average of at least 1.5 hydroxyl groups per molecule, at least 1.8 hydroxyl groups per molecule, or at least 2 hydroxyl groups per molecule. It may contain up to 6 hydroxyl groups per molecule in some embodiments, but, in other embodiments, will contain up to about 3 hydroxyl groups per molecule. The hydroxyl equivalent weight of the polyester polyol can range from about 75 to 4000 or from 150 to 1500.
Suitable polyester polyols include reaction products of hydroxylated compounds, for example diols, with polycarboxylic acids or their anhydrides, such as dicarboxylic acids or dicarboxylic acid anhydrides. The polycarboxylic acids or anhydrides may be aliphatic, cycloaliphatic, aromatic and/or heterocyclic and may be substituted, such as with halogen atoms. The polycarboxylic acids may be unsaturated. Examples of these polycarboxylic acids include succinic acid, adipic acid, terephthalic acid, isophthalic acid, trimellitic anhydride, phthalic anhydride, maleic acid, maleic acid anhydride and fumaric acid. The hydroxylated compounds used in making the polyester polyols may have an equivalent weight of 150 or less, 140 or less, or 125 or less, and include ethylene glycol, 1,2- and 1,3-propylene glycol, 1,4- and 2,3-butane diol, 1,6-hexane diol, 1,8-octane diol, neopentyl glycol, cyclohexane dimethanol, 2-methyl-1,3-propane diol, glycerin, trimethylol propane, 1,2,6-hexane triol, 1,2,4-butane triol, trimethylolethane, pentaerythritol, quinitol, mannitol, sorbitol, methyl glycoside, diethylene glycol, triethylene glycol, tetraethylene glycol, dipropylene glycol, dibutylene glycol, polyethylene glycol, and the like.
Other types of polyols may be used in addition to those provided above. For example, aromatic or aliphatic polyether polyols, aliphatic or aromatic polyether-carbonate polyols, aliphatic or aromatic polyether-ester polyols, and polyols obtained from vegetable derivatives may be used. Accordingly, various combinations of polyols may be used to form the isocyanate-reactive component. For example, other example polyols include VORANOL™ RN490 and VORANOL™ RH360 (polyether polyols formed by adding propylene oxide to sucrose and glycerine and having an average functionality greater than 4 and an EW of 115 and 156, respectively), VORANOL™ RN482 (polyether polyol formed by adding propylene oxide to sorbitol and having a nominal functionality of 6 and an EW of 115), TERCAROL™ 5903 (polyether polyol formed by adding propylene oxide to toluenediamine and having a nominal functionality of 4 and an EW of 127), all available from The Dow Chemical Company (Midland, Mich.).
Other additives, such as chain extenders, cross-linkers, and the like may also be included. Example chain extenders include dipropylene glycol, tripropylene glycol, diethyleneglycol, polypropylene, and polyethylene glycol.
The isocyanate component may include isocyanate-containing reactants that are aliphatic, cycloaliphatic, alicyclic, arylaliphatic, and/or aromatic isocyanates and derivatives thereof. Derivatives may include, by way of example and not limitation, allophanate, biuret, and NCO-terminated prepolymers. According to some embodiments, the isocyanate component includes at least one aromatic isocyanate (e.g., at least one aromatic polyisocyanate). For example, the isocyanate component may include aromatic diisocyanates such as at least one isomer of toluene diisocyanate (TDI), crude TDI, at least one isomer of diphenyl methylene diisocyanate (MDI), crude MDI, and/or higher functional methylene polyphenol polyisocyanate. As used herein, MDI refers to polyisocyanates selected from diphenylmethane diisocyanate isomers, polyphenyl methylene polyisocyanates, and derivatives thereof bearing at least two isocyanate groups. The crude, polymeric, or pure MDI may be reacted with polyols or polyamines to yield modified MDI. Blends of polymeric and monomeric MDI may also be used. In some embodiments, the MDI has an average of from 2 to 3.5 (e.g., from 2 to 3.2) isocyanate groups per molecule. Example isocyanate-containing reactants include those commercially available under the tradename VORANATE™ from The Dow Chemical Company (Midland, Mich.), such as VORANATE™ M229 PMDI isocyanate (a polymeric methylene diphenyl diisocyanate with an average of 2.7 isocyanate groups per molecule).
An isocyanate index for the closed cell polyurethane/polyisocyanurate foam layer may be greater than 180, greater than 195, and/or greater than 200. The isocyanate index may be less than 2,000. For example, in some embodiments, the isocyanate index may be from 180 to 1,500, from 185, to 1,000, from 190 to 750, from 195 to 500, or from 200 to 300. As used herein, “isocyanate index” is the number of equivalents of isocyanate-containing compound added per 100 theoretical equivalents of isocyanate-reactive compound. An isocyanate index of 100 corresponds to one isocyanate group per isocyanate-reactive hydrogen atom present, such as from water and the polyol composition. A higher isocyanate index indicates a higher amount of isocyanate-containing reactant.
A catalyst may also be included in the composition forming the closed cell polyurethane/polyisocyanurate foam layer. Example catalysts that may be used include trimerisation catalysts, which promote reaction of isocyanate with itself, such as tris(dialkylaminoalkyl)-s-hexahydrotriazines (such as 1,3,5-tris(N,N-dimethylaminopropyl)-s-hexahydrotriazine, DABCO™ TMR 30, DABCO™ K-2097 (potassium acetate), DABCO™ K15 (potassium octoate), POLYCAT™ 41, POLYCAT™ 43, POLYCAT™ 46, DABCO™ TMR, CURITHANE™ 52, tetraalkylammonium hydroxides (such as tetramethylammonium hydroxide), alkali metal hydroxides (such as sodium hydroxide), alkali metal alkoxides (such as sodium methoxide and potassium isopropoxide), and alkali metal salts of long-chain fatty acids having 10 to 20 carbon atoms (and in some embodiments, pendant hydroxyl groups).
The closed cell polyurethane/polyisocyanurate foam layer may also include one or more additives. For example, in some embodiments, the closed cell polyurethane/polyisocyanurate foam layer further includes at least one flame retardant. The flame retardant may be present in an amount from 1 wt % to 50 wt % (e.g., 1 wt % to 30 wt %, 1.5 wt % to 20 wt %, 1.5 wt % to 10 wt %, 1.5 wt % to 8 wt %, 2 wt % to 5 wt %, 2.5 wt % to 4 wt %, 2.5 wt % to 3.5 wt %, etc.), based on the total weight of the composition for forming the closed cell polyurethane/polyisocyanurate foam layer. The flame retardant may be a solid or a liquid, and include a non-halogenated flame retardants, a halogenated flame retardant, or combinations thereof. Example flame retardants include, by way of example and not limitation, melamine, expandable graphite, phosphorous compounds with or without halogens, aluminum containing compounds, magnesium based compounds, nitrogen based compounds with or without halogens, chlorinated compounds, brominated compounds, and boron derivatives.
In various embodiments, the closed cell polyurethane/polyisocyanurate foam layer may include a physical blowing agent. As used herein, “physical blowing agents” are low-boiling liquids which volatilize under the curing conditions to form the blowing gas. Exemplary physical blowing agents include hydrocarbons, fluorocarbons, hydrofluorocarbons, hydrofluoroolefins, hydrochlorofluoroolefins, and other halogenated compounds.
The closed cell polyurethane/polyisocyanurate foam layer may have a thickness from 10 mm to 300 mm. For example, the closed cell polyurethane/polyisocyanurate foam layer may have a thickness from 10 mm to 250 mm, from 10 mm to 200 mm, from 10 mm to 150 mm, from 10 mm to 100 mm, from 10 mm to 50 mm, from 10 mm to 25 mm, from 10 mm to 20 mm or the like. The closed cell polyurethane/polyisocyanurate foam layer may be rigid or semi-rigid, but in various embodiments, the closed cell polyurethane/polyisocyanurate foam layer is not brittle.
In various embodiments, the closed cell polyurethane/polyisocyanurate foam layer has a density of less than 100 kg/m3, less than 75 kg/m3, less than 50 kg/m3 and/or less than 40 kg/m3 as measured according to ASTM D 1622. The density may be greater than 10 kg/m3, greater than 20 kg/m3, and/or greater than 30 kg/m3. For example, the density may be from 10 to 100 kg/m3, from 20 to 75 kg/m3, or from 25 to 50 kg/m3.
The closed cell polyurethane/polyisocyanurate foam layer has an open cell volume of less than 20% by volume according to ASTM D 6226, an open cell volume of less than 10% by volume, and/or an open cell volume of less than 8% by volume. In some embodiments, the closed cell polyurethane/polyisocyanurate foam layer has an open cell volume of greater than 0% by volume according to ASTM D 6226, an open cell volume of greater than 0.1% by volume, an open cell volume of greater than 1% by volume, an open cell volume of greater than 2.5% by volume, an open cell volume of greater than 5% by volume and/or an open cell volume of greater than 6% by volume. For example, the closed cell polyurethane/polyisocyanurate foam layer may have an open cell volume of from 0% to 20%, from 0.1% to 10%, or even from about 5% to 8% by volume.
The closed cell polyurethane/polyisocyanurate foam layer may be formed by reacting the isocyanate-reactive component with the isocyanate-containing reactant to form a polymer matrix, along with any additives. In some particular embodiments, the closed cell polyurethane/polyisocyanurate foam layer is a polyurethane/polyisocyanurate foam layer having an isocyanate index of from 180 to 450, a polyester polyol, and a physical blowing agent, and is characterized by an open cell content of less than 20% by volume, and a density of less than 50 kg/m3. In various embodiments, the closed cell foam layer has a thermal conductivity value (k-factor) of less than 26 mW/m*K measured at 10° C., less than 24 mW/m*K measured at 10° C., or even less than 20 mW/m*K measured at 10° C. As is understood by those skilled in the art, lambda or k-factor is a measure of the thermal conductivity of the foam layer, where a lower value indicates improved thermal insulation performance. The k-factor is the measure of heat that passes through one square foot of material that is one inch thick in an hour.
Open Cell Polyurethane/Polyisocyanurate Foam Layer
In various embodiments, the open cell polyurethane/polyisocyanurate foam layer may be formed from a polymer matrix formed by reacting an isocyanate-reactive component with an isocyanate component. In particular, the polymer matrix may include urethane groups, isocyanurate groups, and/or urea groups.
The isocyanate-reactive component includes one or more polyols. In some embodiments, the isocyanate-reactive mixture includes at least one polyether polyol. Various molecular weights are contemplated for the polyether polyol. The polyether polyol may be derived from one or more alkylene oxides such as propylene oxide, ethylene oxide, and/or butylene oxide, as would be understood by a person of ordinary skill in the art. For example, the polyether polyol may be prepared by reacting the one or more alkylene oxides with one or more initiators having from 2 to 10 active hydrogens, in the presence of a polymerization catalyst. Examples of suitable initiators include ethylene glycol, diethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, 1,4-butanediol, 1,6-hexane diol; cycloaliphatic diols such as 1,4-cyclohexane diol, glycerine, trimethanol propane, triethanolamine, sucrose, sorbitol and toluenediamine.
The polyether polyol may have a number average molecular weight of from about 200 g/mol to about 15,000 g/mol. In some embodiments, the molecular weight is greater than about 400 g/mol or greater than about 1000 g/mol. In other embodiments, the molecular weight may be less than about 15000 g/mol, less than about 10,000 g/mol, or less than about 9,000 g/mol. Accordingly, in some embodiments, the polyether polyol has a molecular weight of from about 425 g/mol to about 8500 g/mol or from about 450 g/mol to about 4000 g/mol. Examples of suitable polyether polyols include, but are not limited to, those commercially available under the trademark VORAPEL™, those commercially available under the trademark VORANOL™, such as VORALUX™ HF505, VORANOL™ 8000 LM, VORANOL™ 4000 LM, VORANOL™ 1010 L, VORANOL™ CP 1055, and VORANOL™ CP 260, and those commercially available as Polyglycol P-2000 and Polyglycol P-425, all available from The Dow Chemical Company (Midland, Mich.).
For example, other example polyols include VORANOL™ RN490 and VORANOL™ RH360 (polyether polyols formed by adding propylene oxide to sucrose and glycerine and having an average functionality greater than 4 and an EW of 115 and 156, respectively), VORANOL™ RN482 (polyether polyol formed by adding propylene oxide to sorbitol and having a nominal functionality of 6 and an EW of 115), TERCAROL™ 5903 (polyether polyol formed by adding propylene oxide to toluenediamine and having a nominal functionality of 4 and an EW of 127), all available from The Dow Chemical Company (Midland, Mich.).
As used herein, a hydroxyl number is the milligrams of potassium hydroxide equivalent to the hydroxyl content in one gram of the polyol or other hydroxyl compound. In some embodiments, the resultant polyether polyol has a hydroxyl number of from about 10 mg KOH/g to about 700 mg KOH/g. In still other embodiments, the resultant polyether polyol has a hydroxyl number of from about 275 mg KOH/g to about 400 mg KOH/g. The polyether polyol may have a nominal hydroxyl functionality of from about 2 or greater (e.g., from 2 to 6, from 2 to 5, from 2 to 4, or 2). The polyether polyol may have an average overall hydroxyl functionality of from about 2 to about 4.5 (e.g., 2 to 3.5). As used herein, the hydroxyl functionality (nominal and average overall) is the number of isocyanate reactive sites on a molecule, and may be calculated as the total number of moles of OH over the total number of moles of polyol.
Other types of polyols may be used in addition to those provided above. For example, aliphatic polyester or aromatic polyester polyols, aliphatic or aromatic polyether-carbonate polyols, aliphatic or aromatic polyether-ester polyols, and polyols obtained from vegetable derivatives may be used. Accordingly, various combinations of polyols may be used to form the isocyanate-reactive component.
Other additives, such as chain extenders, flame retardants, cross-linkers, fillers, and the like may also be included. Example chain extenders include dipropylene glycol, tripropylene glycol, diethyleneglycol, polypropylene, and polyethylene glycol.
The flame retardant may be a solid or a liquid, and include a non-halogenated flame retardants, a halogenated flame retardant, or combinations thereof. Example flame retardants include, by way of example and not limitation, melamine, expandable graphite, phosphorous compounds with or without halogens, aluminum containing compounds, magnesium based compounds, nitrogen based compounds with or without halogens, chlorinated compounds, brominated compounds, and boron derivatives.
In certain embodiments the reaction mixture for forming the open-celled polyurethane layer may include a filler. Suitable fillers may be selected from the families of inorganic compounds such as calcium carbonate or of polymeric materials such as polyethylene, polyamide or polytetrafluoroethylene.
The isocyanate component may include isocyanate-containing reactants that are aliphatic, cycloaliphatic, alicyclic, arylaliphatic, and/or aromatic isocyanates and derivatives thereof. Derivatives may include, by way of example and not limitation, allophanate, biuret, and NCO-terminated prepolymers. According to some embodiments, the isocyanate component includes at least one aromatic isocyanate (e.g., at least one aromatic polyisocyanate). For example, the isocyanate component may include aromatic diisocyanates such as at least one isomer of toluene diisocyanate (TDI), crude TDI, at least one isomer of diphenyl methylene diisocyanate (MDI), crude MDI, and/or higher functional methylene polyphenol polyisocyanate. As used herein, MDI refers to polyisocyanates selected from diphenylmethane diisocyanate isomers, polyphenyl methylene polyisocyanates, and derivatives thereof bearing at least two isocyanate groups. The crude, polymeric, or pure MDI may be reacted with polyols or polyamines to yield modified MDI. Blends of polymeric and monomeric MDI may also be used. In some embodiments, the MDI has an average of from 2 to 3.5 (e.g., from 2 to 3.2) isocyanate groups per molecule. Example isocyanate-containing reactants include those commercially available under the tradename VORANATE™ from The Dow Chemical Company (Midland, Mich.), such as VORANATE™ M229 PMDI isocyanate (a polymeric methylene diphenyl diisocyanate with an average of 2.7 isocyanate groups per molecule).
An isocyanate index for the open cell polyurethane/polyisocyanurate foam layer may be greater than 70, greater than 100, greater than 180, greater than 195, and/or greater than 200. The isocyanate index may be less than 2,000. As used herein, “isocyanate index” is the number of equivalents of isocyanate-containing compound added per 100 theoretical equivalents of isocyanate-reactive compound. An isocyanate index of 100 corresponds to one isocyanate group per isocyanate-reactive hydrogen atom present, such as from water and the polyol composition. A higher isocyanate index indicates a higher amount of isocyanate-containing reactant.
A catalyst may also be included in the composition forming the open cell polyurethane/polyisocyanurate foam layer. Example catalysts are tertiary amines like POLYCAT™ 5 and POLYCAT™ 8. Additionally, the catalyst composition may include trimerisation catalysts, which promote reaction of isocyanate with itself, such as tris(dialkylaminoalkyl)-s-hexahydrotriazines (such as 1,3,5-tris(N,N-dimethylaminopropyl)-s-hexahydrotriazine, DABCO™ TMR 30, DABCO™ K-2097 (potassium acetate), DABCO™ K15 (potassium octoate), POLYCAT™ 41, POLYCAT™ 43, POLYCAT™ 46, DABCO™ TMR, CURITHANE™ 52, tetraalkylammonium hydroxides (such as tetramethylammonium hydroxide), alkali metal hydroxides (such as sodium hydroxide), alkali metal alkoxides (such as sodium methoxide and potassium isopropoxide), and alkali metal salts of long-chain fatty acids having 10 to 20 carbon atoms (and in some embodiments, pendant hydroxyl groups).
The open cell polyurethane/polyisocyanurate foam layer also includes one or more blowing agents. The blowing agent is present in an amount to provide the open cell polyurethane/polyisocyanurate foam layer with the desired overall density and open cell content. The blowing agent employed may include carbon dioxide added as a gas or a liquid, or advantageously generated in-situ by the reaction of water with polyisocyanate, optionally in combination with a physical co-blowing agent. Carbon dioxide may also be chemically obtained by other means including the amine/carbon dioxide complexes such as disclosed in U.S. Pat. Nos. 4,735,970 and 4,500,656, the full disclosures of which are hereby incorporated by reference in their entireties, for use as a blowing agent. Other suitable blowing agents include, for example, volatile alkanes such as pentane, hexane or halogen-containing substances such as fluorocarbons and the hydrogen-containing chlorofluorocarbon compounds. The physical blowing agent is not particularly limited. In some particular embodiments, the blowing agent consists essentially of water. Typically for this purpose, the amount of water present is from about 0.5 to about 15, preferably from about 2.0, more preferably from about 3.0, and preferably up to about 10, more preferably up to about 8 parts per 100 parts by weight of polyol. When a physical blowing agent is present, typically the amount is from about 0.5 to about 10, preferably from about 1 to about 5, parts per 100 parts by weight of polyol.
Additionally or alternatively, one or more surfactants may be used in preparing the open cell polyurethane/polyisocyanurate foam layer. For example, in various embodiments, the percentage of open cell versus closed cell in the polyurethane/polyisocyanurate foam may be controlled through the use of cell-opening surfactants. Examples of such cell-opening surfactants include, but are not limited to those sold by Maysta under the trade names AK-9903 and those sold by Momentive under the trade name NIAX™ Silicone L-6164.
The isocyanate-reactive component of the present disclosure can include 0.5 weight percent (wt. %) to 15 wt. % of surfactant, where the wt. % is based on a total weight of the isocyanate-reactive component. Combinations of more than one of each type of surfactant as discussed herein may also be selected, provided their combined percentages in the isocyanate-reactive component as a whole comply with the stated ranges.
The open cell polyurethane/polyisocyanurate foam layer may have a thickness from 5 mm to 80 mm. For example, the open cell polyurethane/polyisocyanurate foam layer may have a thickness from 5 mm to 50 mm, from 5 mm to 30 mm, from 5 mm to 25 mm, from 5 mm to 20 mm, from 5 mm to 15 mm, from 5 mm to 10 mm, or the like. The open cell polyurethane/polyisocyanurate foam layer may be rigid or semi-rigid, but in various embodiments, the open cell polyurethane/polyisocyanurate foam layer is not brittle.
In various embodiments, the open cell polyurethane/polyisocyanurate foam layer has a density of less than 200 kg/m3, less than 100 kg/m3, and/or less than 70 kg/m3 as measured according to ASTM D 1622. The density may be greater than 10 kg/m3, greater than 20 kg/m3, and/or greater than 30 kg/m3. For example, the density may be from 30 to 70 kg/m3 or from 30 to 80 kg/m3.
The open cell polyurethane/polyisocyanurate foam layer has an open cell volume of greater than 50% by volume according to ASTM D 6226, an open cell volume of greater than 60% by volume, an open cell volume of greater than 75% by volume, and/or an open cell volume of greater than 80% by volume. For example, the open cell polyurethane/polyisocyanurate foam layer may have an open cell volume of from 75% to 99%, or from 80% to 95% by volume.
The open cell polyurethane/polyisocyanurate foam layer may be formed by reacting the isocyanate-reactive component with the isocyanate-containing reactant to form a polymer matrix, along with any additives. In some particular embodiments, the open cell polyurethane/polyisocyanurate foam layer is a polyurethane foam layer having an open cell content of greater than 80% by volume, and a density of from 30 to 80 kg/m3.
Facing Layer
As provided above, in some embodiments, the insulation layer 106 may further include at least one facing layer 206. In embodiments, the facing layer 206 may be positioned between the open cell polyurethane/polyisocyanurate foam layer 204 and the closed cell polyurethane/polyisocyanurate foam layer 202, or adjacent to just one of the open cell polyurethane/polyisocyanurate foam layer 204 and the closed cell polyurethane/polyisocyanurate foam layer 202. For example, as shown in
In various embodiments, the facing layer 206 is a non-metal based facing layer, such as a glass-fleece based material. As used herein, “glass-fleece based material” refers to a material that includes glass fleece, such as a glass-fleece substrate. The glass-fleece may be saturated glass-fleece or non-saturated glass-fleece. The non-metal based facings for the insulation component 106 may be selected from glass based material that includes glass fleece, polymer membrane based material, and composite multi-layer foil material.
Example materials suitable for use as facing layers include, for example composite foils including multiple ply laminates of polymers and/or papers, and glass-fleece or glass tissues that may be mineral or bituminous coated. The glass-fleece may be saturated or non-saturated. According to some embodiments, it may be desirable to remove one or more outermost facing layer before use. In some embodiments, the insulation component may have a peel-able facing layer. In such embodiments, the peel-able facing layer may be removed from the insulation component before the insulation component is used. Examples of peel-able facings include polyolefin films (such as, but not limited to, propylene and polyethylene), polyhalogenated polyolefins, waxed paper and waxed plastic films, plastic and composite foils.
In some embodiments, a second facer layer may be included on the insulation component 106 on the opposite face from the first facing layer, such as facing layers 206a and 206c in
In various embodiments, at least one of the closed cell polyurethane/polyisocyanurate foam layer 202 and the open cell polyurethane/polyisocyanurate foam layer 204 may be formed on the facing layer. For example, the closed cell polyurethane/polyisocyanurate foam layer 202 or the open cell polyurethane/polyisocyanurate foam layer 204 may be formed on a surface of the facing layer by application of a liquid reaction mixture to the facing. Additionally or alternatively, one or more of the closed cell polyurethane/polyisocyanurate foam layer 202 and the open cell polyurethane/polyisocyanurate foam layer 204 may be applied to a facing layer in solid form, such as by securing the layer to the facing layer with an adhesive.
In one particular embodiment, the open cell polyurethane/polyisocyanurate foam layer may be formed on a facing layer by applying a liquid reaction mixture to the facing layer. After a delay to allow the open cell polyurethane/polyisocyanurate foam layer to at least partially gel, the liquid reaction mixture for the closed cell polyurethane/polyisocyanurate foam layer may be applied to the open cell polyurethane/polyisocyanurate foam layer. In some embodiments, the delay may be 10 seconds or more. In another particular embodiment, a first reaction mixture for forming the closed-celled polyurethane/polyisocyanurate layer may be dispensed over a first facing. A second facing is then fed and the first facing and the second facing with the reacting mixture there between is allowed to pass through two rotating rolls. Then, a second reaction mixture for forming the open-celled polyurethane/polyisocyanurate layers is dispensed over the outer face of the second facing. A third facing is then laid down as the uppermost layer and the forming panel is allowed to cure travelling through a two spaced apart opposed forming conveyors. Alternatively, an additional facing layer may be applied to the closed cell polyurethane/polyisocyanurate foam layer as the polyurethane foam is formed. Alternatively, the closed cell polyurethane/polyisocyanurate foam layer may be formed on a second facing layer and the open cell polyurethane/polyisocyanurate foam layer and the closed cell polyurethane/polyisocyanurate foam layer may be secured to one another using an adhesive. Other methods of manufacturing the insulation layer 106 may be used. In some particular embodiments, one or more of the outermost facing layers may be removed before use.
The following examples are provided to illustrate various embodiments, but are not intended to limit the scope of the claims. All parts and percentages are by weight unless otherwise indicated. Approximate properties, characters, parameters, etc., are provided below with respect to various working examples, comparative examples, and the materials used in the working and comparative examples. Further, a description of the raw materials used in the examples is as follows:
STEPANPOL™ PS 2352 is a polyester polyol available from Stepan;
STEPANPOL™ PS 3152 is a polyester polyol available from Stepan;
VORANOL™ CP 1055 is a polyether polyol available from The Dow Chemical Company (Midland, Mich.);
TERCAROL™ 5903 is a polyether polyol available from The Dow Chemical Company (Midland, Mich.);
VORANOL™ CP 260 is a polyether polyol available from The Dow Chemical Company (Midland, Mich.);
TCPP is trichloroisopropyl phosphate;
NIAX™ L-6633 is a silicone surfactant available from Momentive Performance Materials, Inc. (Waterford, N.Y.);
NIAX™ L-6164 is an additive available from Momentive Performance Materials, Inc. (Waterford, N.Y.);
POLYCAT™ 5 is a pentamethyl diethylene triamine catalyst available from Evonik Industries;
POLYCAT™ 8 is a tertiary amine catalyst available from Evonik Industries;
DABCO™ K 2097, DABCO™ K 15 and POLYCAT™ 41 are trimerization catalysts available from Evonik Industries;
c/i-pentane 70/30 is a commercially available blend consisting of 70 wt % cyclopentane and 30 wt % of isopentane;
VORANATE™ M 600 is a polymeric methylene diphenyl di-isocyanate (PMDI) available from The Dow Chemical Company (Midland, Mich.); and
VORANATE™ M 220 is a polymeric methylene diphenyl di-isocyanate (PMDI) available from The Dow Chemical Company (Midland, Mich.).
Foam samples were prepared using high pressure dosing-dispensing machines from Afros-Cannon. The isocyanate-reactive component and blowing agent were premixed. The isocyanate-reactive component, blowing agent, and isocyanate were processed at 20±2° C. using a mix pressure of 15,000±2,000 kPa. Open cell content of each foam sample was measured according to ASTM D 6226.
Properties of Comparative Examples A-D are reported together with Examples 1 and 2 in Table 1. Comparative Example A is a closed cell polyurethane/polyisocyanurate foam layer. Comparative Examples B and C are open cell polyurethane/polyisocyanurate foam layers. Comparative Example D is a layer of commercially available white EPS (e.g. PORON 035 from Gruppo Poron). Example 1 is a layer of the closed cell polyurethane/polyisocyanurate foam layer of Comparative Example A positioned between two layers of the open cell polyurethane/polyisocyanurate foam layer of Comparative Example B. Example 2 is a layer of the closed cell polyurethane/polyisocyanurate foam layer of Comparative Example A positioned between two layers of the open cell polyurethane/polyisocyanurate foam layer of Comparative Example C. In particular, in Examples 1 and 2, the closed cell polyurethane/polyisocyanurate foam layer was glued to each of the open cell polyurethane/polyisocyanurate foam layer.
The open cell layers of Comparative Examples B and C were prepared according to the “open cell” formulation in Table 1. Comparative Example B was taken from a free-rise foam bun, while Comparative Example C was prepared applying a certain over-packing in a closed mold. The closed cell foam of Comparative Example A was prepared according to the “closed cell” formulation in Table 1, produced in a continuous lamination process.
Dimensional changes of an 80 mm×80 mm×80 mm specimen after a 4-day thermal cycle (2 days at 70° C., 90% RH and 2 days at 70° C., 25% RH) of Examples 1 and 2 and Comparative Example A were measured and are reported in Table 2.
As shown in Table 2, the dimensional changes for Examples 1 and 2 are closer to 0 than for Comparative Example A, indicating that the open cell layers can provide improved dimensional stability for closed cell foams when used in combination.
The thermal insulation of the Comparative Example A and C was measured by means of a LaserComp heat flow meter instrument at 10° C. The specimen dimensions were 200 mm×200 mm×50 mm (thickness). The thermal resistance (R-value) of Example 2 was then calculated from the thermal conductivity values of the different layers. The R-value of Example 2, while slightly lower than the Comparative Example A, was by far better than conventional insulation products used for ETICS applications such as EPS, gray EPS or mineral wool whose R values for same thickness are lower than 2.67 m2K/W.
Various embodiments described demonstrate that the multilayered panel, while showing a certain worsening of thermal resistance compared with a board consisting exclusively of closed celled foam (Comparative Example A) provides much better thermal insulation when compared with common materials presently used for ETICS applications (Comparative Example D). Accordingly, various embodiments described herein may be employed in thermal insulation composite applications where improved dimensional stability is desired.
It is further noted that terms like “generally,” “commonly,” and “typically” are not utilized herein to limit the scope of the claimed invention or to imply that certain features are critical, essential, or even important to the structure or function of the claimed invention. Rather, these terms are merely intended to highlight alternative or additional features that may or may not be utilized in a particular embodiment of the present disclosure.
It will be apparent that modifications and variations are possible without departing from the scope of the disclosure defined in the appended claims. More specifically, although some aspects of the present disclosure are identified herein as preferred or particularly advantageous, it is contemplated that the present disclosure is not necessarily limited to these aspects.
Number | Date | Country | Kind |
---|---|---|---|
102017000136482 | Nov 2017 | IT | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2018/059525 | 11/7/2018 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2019/108350 | 6/6/2019 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2323936 | Roberts | Jul 1943 | A |
3565746 | Stevens | Feb 1971 | A |
3582095 | Bogaert | Jun 1971 | A |
3657036 | Mullenhoff | Apr 1972 | A |
3677874 | Sterrett | Jul 1972 | A |
3694385 | Salyer et al. | Sep 1972 | A |
3991252 | Kolakowski et al. | Nov 1976 | A |
4042746 | Hofer | Aug 1977 | A |
4130614 | Saidla | Dec 1978 | A |
4318258 | Heck | Mar 1982 | A |
4414265 | Rosato | Nov 1983 | A |
4451587 | Keshi | May 1984 | A |
4500656 | Rasshofer et al. | Feb 1985 | A |
4548861 | Barnes | Oct 1985 | A |
4555442 | Frentzel | Nov 1985 | A |
4735970 | Sommerfeld et al. | Apr 1988 | A |
4869037 | Murphy | Sep 1989 | A |
4938819 | Ishii | Jul 1990 | A |
4943597 | Grunbauer | Jul 1990 | A |
4977018 | Irrgeher | Dec 1990 | A |
5285607 | Somerville | Feb 1994 | A |
5318997 | Okada | Jun 1994 | A |
5420169 | Schumacher | May 1995 | A |
5473847 | Crookston | Dec 1995 | A |
5523334 | White, III | Jun 1996 | A |
5589243 | Day | Dec 1996 | A |
5654344 | Falke | Aug 1997 | A |
5784845 | Imeokparia | Jul 1998 | A |
5856678 | Smits | Jan 1999 | A |
5882776 | Bambara | Mar 1999 | A |
5889067 | Jang | Mar 1999 | A |
5998494 | Hamilton | Dec 1999 | A |
6108991 | Hagan | Aug 2000 | A |
6114403 | Mercando | Sep 2000 | A |
6314695 | Belleau | Nov 2001 | B1 |
6316514 | Falke | Nov 2001 | B1 |
6552098 | Bosch | Apr 2003 | B1 |
6743483 | Rochefort et al. | Jun 2004 | B2 |
8397465 | Hansbro et al. | Mar 2013 | B2 |
8426017 | Paradis et al. | Apr 2013 | B2 |
8470436 | Paradis et al. | Jun 2013 | B1 |
8479467 | Johnson et al. | Jul 2013 | B2 |
8597779 | Paradis et al. | Dec 2013 | B2 |
8617699 | Paradis et al. | Dec 2013 | B2 |
20010014387 | Giampaolo | Aug 2001 | A1 |
20030041544 | Rusek, Jr. | Mar 2003 | A1 |
20040014382 | MacAulay | Jan 2004 | A1 |
20040014828 | Haider | Jan 2004 | A1 |
20040162359 | Barber | Aug 2004 | A1 |
20040180978 | Dreier | Sep 2004 | A1 |
20040200171 | Schilger | Oct 2004 | A1 |
20040229030 | Owensby | Nov 2004 | A1 |
20040242717 | Beatty | Dec 2004 | A1 |
20050014857 | Heinemann | Jan 2005 | A1 |
20050055973 | Hagen | Mar 2005 | A1 |
20050144901 | Egan | Jul 2005 | A1 |
20050188649 | Hagen, Jr. | Sep 2005 | A1 |
20060014846 | Sparks | Jan 2006 | A1 |
20060021823 | Kohara | Feb 2006 | A1 |
20060027948 | Grass | Feb 2006 | A1 |
20060096205 | Griffin | May 2006 | A1 |
20060179749 | Brandt | Aug 2006 | A1 |
20060258762 | Dobransky et al. | Nov 2006 | A1 |
20060275561 | Agrawal | Dec 2006 | A1 |
20070110976 | Pastore | May 2007 | A1 |
20070234667 | Lubker, II | Oct 2007 | A1 |
20080200574 | Janzen | Aug 2008 | A1 |
20080234402 | Lehmann et al. | Sep 2008 | A1 |
20080269365 | Andrew et al. | Oct 2008 | A1 |
20080307715 | Pufahl | Dec 2008 | A1 |
20090011203 | Mock | Jan 2009 | A1 |
20090124718 | Lekovic | May 2009 | A1 |
20100031603 | Letts et al. | Feb 2010 | A1 |
20100087562 | Diloreto | Apr 2010 | A1 |
20110168217 | Neff | Jul 2011 | A1 |
20110196055 | Kramer | Aug 2011 | A1 |
20110197530 | Bahnmiller | Aug 2011 | A1 |
20110229693 | Maurer | Sep 2011 | A1 |
20110258762 | Schultz | Oct 2011 | A1 |
20110284320 | Bongiovi | Nov 2011 | A1 |
20110313072 | Maurer et al. | Dec 2011 | A1 |
20120028563 | Sacks | Feb 2012 | A1 |
20120085063 | Pufahl | Apr 2012 | A1 |
20120216476 | Naidoo | Aug 2012 | A1 |
20120237759 | Ehbing | Sep 2012 | A1 |
20120251727 | Shimizu | Oct 2012 | A1 |
20120317914 | Bomberg et al. | Dec 2012 | A1 |
20130104480 | Smith | May 2013 | A1 |
20130164524 | Letts | Jun 2013 | A1 |
20130209778 | Albach | Aug 2013 | A1 |
20130227902 | Van Sloun | Sep 2013 | A1 |
20130318911 | Sealock | Dec 2013 | A1 |
20140115989 | Sievers | May 2014 | A1 |
20140115991 | Sievers | May 2014 | A1 |
20140151593 | Yin | Jun 2014 | A1 |
20140275305 | Svenson | Sep 2014 | A1 |
20140308492 | Albach | Oct 2014 | A1 |
20150038610 | Peters | Feb 2015 | A1 |
20150093535 | Lambach | Apr 2015 | A1 |
20150101276 | Lohmann | Apr 2015 | A1 |
20150111001 | Sagnard et al. | Apr 2015 | A1 |
20150210035 | Rippel | Jul 2015 | A1 |
20160046758 | Boehnke | Feb 2016 | A1 |
20160090460 | Singh | Mar 2016 | A1 |
20160194866 | Jones | Jul 2016 | A1 |
20160272774 | Snider | Sep 2016 | A1 |
20160361892 | Ciuperca | Dec 2016 | A1 |
20170209897 | Clamor | Jul 2017 | A1 |
20170241131 | Lewis | Aug 2017 | A1 |
20170313806 | Yu et al. | Nov 2017 | A1 |
20170326849 | White et al. | Nov 2017 | A1 |
20170368785 | Fox | Dec 2017 | A1 |
20180112394 | Giles | Apr 2018 | A1 |
20180245335 | Schlüter | Aug 2018 | A1 |
20180320370 | Letts | Nov 2018 | A1 |
20180363298 | Giles | Dec 2018 | A1 |
20190048163 | McAdams | Feb 2019 | A1 |
20190127542 | El-Khatib | May 2019 | A1 |
20190194379 | Bindschedler | Jun 2019 | A1 |
20190383031 | Baert | Dec 2019 | A1 |
20200013384 | Hasegawa | Jan 2020 | A1 |
20200298531 | Bertucelli | Sep 2020 | A1 |
20200362553 | Vairo | Nov 2020 | A1 |
20200368996 | Katsura | Nov 2020 | A1 |
20210115184 | Diloreto | Apr 2021 | A1 |
Number | Date | Country |
---|---|---|
666885 | Feb 1996 | AU |
893737 | Nov 1982 | BE |
1126138 | Jul 1996 | CN |
1281401 | Jan 2001 | CN |
1417437 | May 2003 | CN |
1455791 | Nov 2003 | CN |
2606140 | Mar 2004 | CN |
1532037 | Sep 2004 | CN |
1737285 | Feb 2006 | CN |
1775521 | May 2006 | CN |
1827978 | Sep 2006 | CN |
101109212 | Jan 2008 | CN |
101275410 | Oct 2008 | CN |
101618611 | Jan 2010 | CN |
101967861 | Feb 2011 | CN |
102108769 | Jun 2011 | CN |
201891191 | Jul 2011 | CN |
102251638 | Nov 2011 | CN |
106032686 | Oct 2016 | CN |
106084749 | Nov 2016 | CN |
205804651 | Dec 2016 | CN |
107163209 | Sep 2017 | CN |
2915474 | Nov 1980 | DE |
4321877 | Sep 1994 | DE |
102010000600 | Oct 2010 | DE |
025741 | Jan 2017 | EA |
0013731 | Aug 1980 | EP |
159454 | Oct 1985 | EP |
952266 | Oct 1999 | EP |
1201838 | May 2002 | EP |
03012224 | Feb 2003 | EP |
1516720 | Mar 2005 | EP |
1621696 | Feb 2006 | EP |
2186958 | May 2010 | EP |
2644374 | Oct 2013 | EP |
2905117 | Aug 2015 | EP |
2514387 | Apr 1983 | FR |
2722811 | Jan 1996 | FR |
59142137 | Aug 1984 | JP |
H02277623 | Nov 1990 | JP |
09096021 | Apr 1997 | JP |
10244609 | Sep 1998 | JP |
2000026567 | Jan 2000 | JP |
2000052466 | Feb 2000 | JP |
2001232709 | Aug 2001 | JP |
2001247647 | Sep 2001 | JP |
2002370300 | Dec 2002 | JP |
2004092312 | Mar 2004 | JP |
2008308981 | Dec 2008 | JP |
2015525316 | Sep 2015 | JP |
2006026780 | Mar 2006 | KR |
926834 | Nov 2009 | KR |
8300524 | Sep 1984 | NL |
1010514 | May 2000 | NL |
2441119 | Aug 2009 | RU |
150450 | Feb 2015 | RU |
2645558 | Feb 2018 | RU |
1183642 | Oct 1985 | SU |
WO-9636655 | Nov 1996 | WO |
WO-9960045 | Nov 1999 | WO |
2002022702 | Mar 2002 | WO |
03012224 | Feb 2003 | WO |
WO-2007095961 | Aug 2007 | WO |
WO-2008145372 | Dec 2008 | WO |
2013053566 | Apr 2013 | WO |
2013098859 | Jul 2013 | WO |
2014158512 | Oct 2014 | WO |
2015091801 | Jun 2015 | WO |
2015161024 | Oct 2015 | WO |
WO-2015165870 | Nov 2015 | WO |
WO-2016178866 | Nov 2016 | WO |
Entry |
---|
Machine Translation of FR-2722811-A1, Jan. 1996 (Year: 1996). |
Machine Translation of JP-10244609-A, Sep. 1998 (Year: 1998). |
Machine Translation of KR-926834-B1, Nov. 2009 (Year: 2009). |
Machine Translation of DE-102010000600-A1, Oct. 2010 (Year: 2010). |
Machine Translation of EP-2905117-A1, Aug. 2015 (Year: 2015). |
European Office Action dated Oct. 26, 2021, pertaining to European Patent Application No. 18759536.8, 10 pgs. |
Russian Office Action dated Dec. 16, 2021, pertaining to Russian Patent Application No. 2020119817, 8 pgs. |
Indian Office Action dated Dec. 31, 2021, pertaining to Indian Patent Application No. 202017023541, 5 pgs. |
Chinese Office Action dated Jan. 18, 2022, pertaining to Chinese Patent Application No. 201880080823.6, 12 pgs. |
Notice of Reasons for Refusal dated Oct. 18, 2022, pertaining to JP Patent Application No. 2020-528204, 8 pgs. |
Search Report dated Oct. 19, 2022, pertaining to JP Patent Application No. 2020-528204, 21 pgs. |
Japanese Office Action dated Aug. 23, 2022, pertaining to JP Patent No. 2020-528303, 4 total pages (English translation of the Office Action). |
International Search Report and Written Opinion pertaining to PCT/US2018/059522, dated Jan. 16, 2019. |
Italian Search Report and Written Opinion pertaining to Italian Patent Application No. 102017000136462, dated Jun. 5, 2018. |
International Search Report and Written Opinion pertaining to PCT/US2018/047840, dated Nov. 26, 2018. |
Italian Search Report and Written Opinion pertaining to Italian Patent Application No. 102017000136495, dated Jun. 5, 2018. |
Article 94(3) dated Feb. 25, 2022, pertaining to EP Patent Application No. 18882743.0, 7 pgs. |
Article 94(3) dated Oct. 21, 2021, pertaining to EP Patent Application No. 18883528.4, 4 pgs. |
Examination Report dated Nov. 11, 2021, pertaining to IN Patent Application No. 202017023543, 10 pgs. |
English Translation of Office Action dated Jan. 14, 2022, pertaining to CN Patent Application No. 201880082855.X, 5 pgs. |
Office Action dated Mar. 1, 2022, pertaining to RU Patent Application No. 2020120512, 10 pgs. |
Examination Report dated Mar. 25, 2022, pertaining to IN Patent Application No. 202017023542, 7 pgs. |
Office Action dated Mar. 10, 2022, pertaining to RU Patent Application No. 2020120216, 11 pgs. |
Office Action dated Apr. 24, 2022, pertaining to CN Patent Application No. 201880081542.2, 15 pgs. |
International Search Report and Written Opinion pertaining to PCT/US2018/059525, dated Jan. 22, 2019. |
Italian Search Report and Written Opinion pertaining to Italian Patent Application No. 102017000136482, dated May 18, 2018. |
Number | Date | Country | |
---|---|---|---|
20200353716 A1 | Nov 2020 | US |